BONE, Inc. (NASDAQ:SIBN), recently sold shares of the company's common stock. The medical device company, currently valued at approximately $754 million, has shown strong momentum with a nearly 29% ...

https://www.tipranks.com/news/the-fly/pepgen-price-target-lowered-to-16-from-26-at-h-c-wainwright Needham raised the firm’s price target on SI-Bone (SIBN) to $20 ...

Quantum-Si is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, ...

Fintel reports that on February 7, 2025, Alliance Global Partners initiated coverage of Quantum-Si (NasdaqGM:QSI) with a Buy ...

These ratings convey the analysts' expectations for the relative performance of Quantum-Si compared to the broader market. Price Targets: Analysts gauge the dynamics of price targets, providing ...

Stifel raised the firm’s price target on SiTime (SITM) to $270 from $250 and keeps a Buy rating on the shares after a December quarter beat and ...

--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq ... and sale of 15,625,000 shares of common stock at a purchase price of $3.20 per share, pursuant to a registered direct offering, resulting ...

Observing a 6.67% increase, the current average has risen from the previous average price target of $3.75. The analysis of recent analyst actions sheds light on the perception of Quantum-Si by ...